V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300007361 | 300003958 | null | 43.2 | null | 2015-07-27 | 2015-08-02 | Cisplatin + Radiotherapy | 2 | null | 300007628 | CISPLATIN + RT |
| 300007362 | 300003959 | null | 52 | Curative (C) | 2015-08-24 | 2015-09-20 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 300007637 | CISPLATIN + RT |
| 300007363 | 300003963 | null | 78.5 | Curative (C) | 2018-04-06 | 2018-05-08 | CISPLATIN + RT | null | null | 300007705 | CISPLATIN + RT |
| 300007364 | 300003965 | 1.81 | 93 | Palliative (P) | 2019-03-29 | 2019-03-31 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 300007729 | FLUOROURACIL |
| 300007365 | 300003967 | 1.65 | null | Palliative (P) | 2017-02-19 | 2017-03-02 | CARBOPLATIN + RT | null | null | 300007738 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007366 | 300003968 | 1.81 | 130 | Palliative (P) | 2017-08-08 | 2017-11-21 | ETOPOSIDE | 2 | N | 300007747 | OXALIPLATIN + MDG |
| 300007367 | 300003972 | 1.76 | 65 | null | 2016-10-10 | 2017-07-14 | Capecitabine | N | N | 300007800 | CISPLATIN |
| 300007368 | 300006603 | 1.65 | null | null | 2016-08-26 | 2016-09-11 | Trial Unspecified | null | null | 300007801 | DE-ESCALATE TRIAL |
| 300007369 | 300003978 | 1.6 | 115.7 | Palliative (P) | 2016-11-11 | 2016-11-18 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300007829 | TRIAL |
| 300007370 | 300003979 | 1.49 | 62.8 | Curative (C) | 2016-07-29 | 2016-08-29 | CAV | null | null | 300007831 | OXALIPLATIN |
| 300007371 | 300003981 | null | null | Neo-adjuvant (N) | 2016-08-12 | 2016-08-19 | DE-ESCALATE TRIAL | null | null | 300007852 | PEMETREXED |
| 300007372 | 300003984 | 1.58 | 70.3 | Palliative (P) | 2018-06-21 | 2018-07-29 | PEMBROLIZUMAB | N | N | 300007863 | CARBOPLATIN |
| 300007373 | 300003987 | 1.71 | 90.3 | Palliative (P) | 2015-08-19 | 2016-09-05 | CARBOPLATIN + RT | 02 | N | 300007885 | CISPLATIN + FLUOROURACIL |
| 300007374 | 300003990 | 1.65 | null | Palliative (P) | 2018-06-22 | 2018-06-30 | Carboplatin AUC 6 - 10 | N | null | 300007889 | DE-ESCALATE TRIAL |
| 300007375 | 300003994 | 1.8 | 92.7 | Palliative (P) | 2013-03-09 | 2013-07-06 | PEMBROLIZUMAB | 01 | N | 300007910 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300007376 | 300003995 | 1.91 | 55 | Palliative (P) | 2016-06-19 | 2016-06-28 | NIVOLUMAB | N | N | 300007912 | STAMPEDE TRIAL |
| 300007377 | 300004001 | 1.58 | 58 | Palliative (P) | 2016-08-25 | 2016-09-25 | Capecitabine | 02 | null | 300007959 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007378 | 300004003 | 1.49 | 73.5 | Palliative (P) | 2014-07-18 | 2014-08-13 | Capecitabine | 2 | N | 300007960 | IRINOTECAN + MDG |
| 300007379 | 300004009 | 1.65 | 91.4 | Adjuvant (A) | 2015-07-08 | 2016-01-28 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300007975 | COMPARE TRIAL |
| 300007380 | 300004011 | 1.54 | 40 | null | 2014-11-20 | 2014-11-26 | Carboplatin AUC 6 - 10 | null | N | 300007983 | ESPAC TRIAL |
| 300007381 | 300004018 | 1.77 | 79 | Palliative (P) | 2016-05-05 | 2016-05-31 | CAPECITABINE + RT | N | N | 300008054 | CETUXIMAB |
| 300007382 | 300004022 | 1.82 | null | Palliative (P) | 2014-08-29 | 2014-09-05 | CISPLATIN + FLUOROURACIL | N | N | 300008108 | CAPECITABINE + OXALIPLATIN |
| 300007383 | 300004023 | 1.63 | 82.2 | Curative (C) | 2017-06-24 | 2017-06-24 | GemCarbo Days 1+8 | 02 | N | 300008116 | PEMBROLIZUMAB |
| 300007384 | 300006631 | 1.73 | null | Curative (C) | 2014-06-29 | 2015-05-28 | KESTREL Trial | N | null | 300008148 | FLUOROURACIL + MITOMYCIN |
| 300007385 | 300004027 | 1.64 | 58.8 | Palliative (P) | 2017-09-18 | 2017-11-01 | NIVOLUMAB | 02 | N | 300008195 | CARBOPLATIN + LIPOSOMAL DOX |
| 300007386 | 300004029 | 1.76 | 57 | Palliative (P) | 2015-04-26 | 2015-04-29 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 300008206 | CISPLATIN + FLUOROURACIL |
| 300007387 | 300004031 | 1.78 | 60 | Curative (C) | 2017-09-22 | 2017-10-17 | Cetuximab 7 day (>Cycle 2) | N | Y | 300008231 | CARBOPLATIN |
| 300007388 | 300004031 | 1.72 | 68.8 | Curative (C) | 2016-06-25 | 2016-07-16 | Carboplatin + Etoposide iv&po | 02 | N | 300008231 | ESPAC TRIAL |
| 300007389 | 300004034 | 1.62 | 65 | null | 2016-07-04 | 2016-07-05 | DE-ESCALATE TRIAL | null | null | 300008267 | DE-ESCALATE TRIAL |
| 300007390 | 300004035 | 1.8 | 59.9 | Curative (C) | 2018-01-24 | 2018-02-07 | CARBOPLATIN + RT | N | Y | 300008275 | CARBOPLATIN |
| 300007391 | 300004043 | 1.63 | 44.6 | Palliative (P) | 2018-02-11 | 2018-02-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300008338 | CAPECITABINE + GEMCITABINE |
| 300007392 | 300004043 | 1.57 | 58.4 | Adjuvant (A) | 2016-07-05 | 2016-07-05 | Capecitabine | N | N | 300008338 | CETUXIMAB |
| 300007393 | 300004046 | 1.71 | null | Curative (C) | 2016-05-06 | 2016-05-07 | Cisplatin | N | Y | 300008401 | CARBOPLATIN + RT |
| 300007394 | 300004047 | 1.56 | 72.4 | Palliative (P) | 2018-02-24 | 2018-06-15 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300008405 | CYTARABINE |
| 300007395 | 300004049 | 1.67 | 60.6 | Palliative (P) | 2018-12-11 | 2018-12-12 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 300008410 | CAPECITABINE + GEMCITABINE |
| 300007396 | 300004054 | 1.85 | null | Adjuvant (A) | 2017-08-09 | 2017-08-24 | Cisplatin +Fluorouracil (3 wk) | N | N | 300008456 | CARBOPLATIN |
| 300007397 | 300004056 | 1.59 | 46.6 | Palliative (P) | 2016-10-20 | 2016-11-15 | Vinorelbine (oral) | 02 | N | 300008474 | ECX |
| 300007398 | 300007679 | 1.73 | null | Palliative (P) | 2018-10-13 | 2018-10-21 | IPILIMUMAB + NIVOLUMAB | N | N | 300008489 | CARBOPLATIN |
| 300007399 | 300004060 | 1.61 | 0 | Palliative (P) | 2018-03-12 | 2018-04-09 | Carboplatin + Etoposide iv&po | 02 | N | 300008495 | CARBOPLATIN + PACLITAXEL |
| 300007400 | 300004061 | 1.49 | null | Palliative (P) | 2016-08-02 | 2016-08-16 | Carboplatin AUC 6 - 10 | null | null | 300008533 | DE-ESCALATE TRIAL |
| 300007401 | 300004063 | 1.71 | 58.1 | Palliative (P) | 2016-10-02 | 2016-10-04 | CompARE Trial | N | N | 300008549 | CISPLATIN + FLUOROURACIL |
| 300007402 | 300004065 | 1.76 | 54.2 | Palliative (P) | 2017-01-13 | 2017-02-04 | Carboplatin AUC 2 - 5 | 02 | N | 300008554 | BEVACIZUMAB |
| 300007403 | 300004067 | 1.72 | null | Adjuvant (A) | 2014-11-07 | 2014-11-07 | Cisplatin | 02 | Y | 300008567 | CARBOPLATIN |
| 300007404 | 300004068 | 1.55 | 90.6 | Curative (C) | 2015-10-05 | 2015-10-19 | GemCarbo Days 1+8 | 02 | N | 300008585 | OXALIPLATIN + MDG |
| 300007405 | 300004069 | null | null | Palliative (P) | null | 2015-02-20 | Capecitabine | N | N | 300008587 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007406 | 300006661 | 1.82 | null | Palliative (P) | 2013-08-22 | 2015-12-30 | CARBOPLATIN + RT | N | Y | 300008620 | CETUXIMAB + RT |
| 300007407 | 300007684 | 1.66 | 67.9 | Adjuvant (A) | 2018-05-04 | 2018-05-11 | Carboplatin AUC 6 - 10 | null | null | 300008687 | CETUXIMAB |
| 300007408 | 300004081 | 1.61 | null | null | 2018-07-19 | 2018-07-21 | CISPLATIN + FLUOROURACIL | 02 | N | 300008708 | IRINOTECAN + MDG |
| 300007409 | 300004082 | null | 55.7 | Adjuvant (A) | 2018-12-03 | 2019-05-26 | CETUXIMAB | null | null | 300008712 | CARBOPLATIN + RT |
| 300007410 | 300004084 | 1.78 | 56 | Palliative (P) | 2015-12-19 | 2015-12-30 | null | 2 | N | 300008724 | CAPECITABINE + OXALIPLATIN |